Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

AstraZeneca PLC (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
10,914.0 +52.0    +0.48%
18/04 - Closed. Currency in GBP ( Disclaimer )
Type:  Equity
Market:  United Kingdom
ISIN:  GB0009895292 
SEDOL:  0989529
  • Volume: 2,114,901
  • Bid/Ask: 10,904.0 / 10,922.0
  • Day's Range: 10,858.0 - 11,018.0
AstraZeneca 10,914.0 +52.0 +0.48%

AZN Income Statement

 
Featured here, the Income Statement (earnings report) for AstraZeneca PLC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 12024 11492 11416 10879
Revenue 12024 11492 11416 10879
Other Revenue, Total - - - -
Cost of Revenue, Total 2295 2055 1917 1773
Gross Profit 9729 9437 9499 9106
Total Operating Expenses 9990 8959 8814 8192
Selling/General/Admin. Expenses, Total 4891 4440 5054 4150
Research & Development 2935 2534 2627 2308
Depreciation / Amortization -790 268 259 260
Interest Expense (Income) - Net Operating -38 -392 -431 -365
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 697 54 -612 66
Operating Income 2034 2533 2602 2687
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 51 - - 241
Other, Net 1086 881 514 184
Net Income Before Taxes 897 1652 2088 2262
Provision for Income Taxes -62 274 268 458
Net Income After Taxes 959 1378 1820 1804
Minority Interest 23 24 24 22
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 960 1374 1818 1803
Total Extraordinary Items - - - -
Net Income 960 1374 1818 1803
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 960 1374 1818 1803
Dilution Adjustment 0.78 1.2 -7.2 -6.6
Diluted Net Income 959.22 1372.8 1825.2 1809.6
Diluted Weighted Average Shares 1561 1560 1560 1560
Diluted EPS Excluding Extraordinary Items 0.614 0.88 1.17 1.16
DPS - Common Stock Primary Issue 1.97 - 0.93 -
Diluted Normalized EPS 0.695 0.891 0.894 0.961
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email